640 related articles for article (PubMed ID: 30541458)
1. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease.
Ong C; Lim PT; Logarajah V; Liwanag MJ; Ang BX; Cher Y; Chiou FK; Kader A
BMC Gastroenterol; 2018 Dec; 18(1):185. PubMed ID: 30541458
[TBL] [Abstract][Full Text] [Related]
2. Early Mucosal Healing with Exclusive Enteral Nutrition is Associated with Improved Outcomes in Newly Diagnosed Children with Luminal Crohn's disease.
Grover Z; Burgess C; Muir R; Reilly C; Lewindon PJ
J Crohns Colitis; 2016 Oct; 10(10):1159-64. PubMed ID: 26980840
[TBL] [Abstract][Full Text] [Related]
3. Repeated exclusive enteral nutrition in the treatment of paediatric Crohn's disease: predictors of efficacy and outcome.
Frivolt K; Schwerd T; Werkstetter KJ; Schwarzer A; Schatz SB; Bufler P; Koletzko S
Aliment Pharmacol Ther; 2014 Jun; 39(12):1398-407. PubMed ID: 24779671
[TBL] [Abstract][Full Text] [Related]
4. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach.
Day AS; Whitten KE; Lemberg DA; Clarkson C; Vitug-Sales M; Jackson R; Bohane TD
J Gastroenterol Hepatol; 2006 Oct; 21(10):1609-14. PubMed ID: 16928225
[TBL] [Abstract][Full Text] [Related]
5. Time to Relapse in Children with Crohn's Disease Treated with Azathioprine and Nutritional Therapy or Corticosteroids.
Hradsky O; Copova I; Zarubova K; Nevoral J; Bronsky J
Dig Dis Sci; 2016 Jul; 61(7):2041-50. PubMed ID: 26971092
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset moderate-to-severe luminal paediatric Crohn's disease.
Jongsma MME; Vuijk SA; Cozijnsen MA; van Pieterson M; Norbruis OF; Groeneweg M; Wolters VM; van Wering HM; Hojsak I; Kolho KL; van Wijk MP; Teklenburg-Roord STA; de Meij TGJ; Escher JC; de Ridder L
Eur J Pediatr; 2022 Aug; 181(8):3055-3065. PubMed ID: 35672586
[TBL] [Abstract][Full Text] [Related]
7. Use of exclusive enteral nutrition in paediatric Crohn's disease in The Netherlands.
de Bie C; Kindermann A; Escher J
J Crohns Colitis; 2013 May; 7(4):263-70. PubMed ID: 22820027
[TBL] [Abstract][Full Text] [Related]
8. Tolerance and efficacy of azathioprine in pediatric Crohn's disease.
Riello L; Talbotec C; Garnier-Lengliné H; Pigneur B; Svahn J; Canioni D; Goulet O; Schmitz J; Ruemmele FM
Inflamm Bowel Dis; 2011 Oct; 17(10):2138-43. PubMed ID: 21910176
[TBL] [Abstract][Full Text] [Related]
9. [Exclusive enteral nutrition continues to be first line therapy for pediatric Crohn's disease in the era of biologics].
Navas-López VM; Blasco-Alonso J; Lacasa Maseri S; Girón Fernández-Crehuet F; Serrano Nieto MJ; Vicioso Recio MI; Sierra Salinas C
An Pediatr (Barc); 2015 Jul; 83(1):47-54. PubMed ID: 24704330
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study showing maintenance treatment options for paediatric CD in the first year following diagnosis after induction of remission with EEN: supplemental enteral nutrition is better than nothing!
Duncan H; Buchanan E; Cardigan T; Garrick V; Curtis L; McGrogan P; Barclay A; Russell RK
BMC Gastroenterol; 2014 Mar; 14():50. PubMed ID: 24645851
[TBL] [Abstract][Full Text] [Related]
11. Partial enteral nutrition induces clinical and endoscopic remission in active pediatric Crohn's disease: results of a prospective cohort study.
Urlep D; Benedik E; Brecelj J; Orel R
Eur J Pediatr; 2020 Mar; 179(3):431-438. PubMed ID: 31781933
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of induction therapy with exclusive enteral nutrition in pediatric Crohn's disease].
Luo YY; Fang YH; Yu JD; Xu LJ; Sun MF; Cheng Q; Chen J
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jun; 24(6):626-630. PubMed ID: 35762427
[TBL] [Abstract][Full Text] [Related]
13. Two-Year Outcomes After Exclusive Enteral Nutrition Induction Are Superior to Corticosteroids in Pediatric Crohn's Disease Treated Early with Thiopurines.
Grover Z; Lewindon P
Dig Dis Sci; 2015 Oct; 60(10):3069-74. PubMed ID: 26038093
[TBL] [Abstract][Full Text] [Related]
14. Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn's disease.
Grover Z; Muir R; Lewindon P
J Gastroenterol; 2014 Apr; 49(4):638-45. PubMed ID: 23636735
[TBL] [Abstract][Full Text] [Related]
15. Exclusive Enteral Nutrition Therapy in Paediatric Crohn's Disease Results in Long-term Avoidance of Corticosteroids: Results of a Propensity-score Matched Cohort Analysis.
Connors J; Basseri S; Grant A; Giffin N; Mahdi G; Noble A; Rashid M; Otley A; Van Limbergen J
J Crohns Colitis; 2017 Sep; 11(9):1063-1070. PubMed ID: 28575325
[TBL] [Abstract][Full Text] [Related]
16. Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course.
Harris RE; Aloi M; de Ridder L; Croft NM; Koletzko S; Levine A; Turner D; Veereman G; Neyt M; Bigot L; Ruemmele FM; Russell RK;
BMJ Open; 2020 Jul; 10(7):e034892. PubMed ID: 32611737
[TBL] [Abstract][Full Text] [Related]
17. Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.
Levine A; Wine E; Assa A; Sigall Boneh R; Shaoul R; Kori M; Cohen S; Peleg S; Shamaly H; On A; Millman P; Abramas L; Ziv-Baran T; Grant S; Abitbol G; Dunn KA; Bielawski JP; Van Limbergen J
Gastroenterology; 2019 Aug; 157(2):440-450.e8. PubMed ID: 31170412
[TBL] [Abstract][Full Text] [Related]
18. Exclusive enteral nutrition versus corticosteroids for treatment of pediatric Crohn's disease: a meta-analysis.
Yu Y; Chen KC; Chen J
World J Pediatr; 2019 Feb; 15(1):26-36. PubMed ID: 30666565
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Response to Exclusive Enteral Nutrition in Newly Diagnosed Crohn´s Disease in Children: PRESENCE Study from SEGHNP.
Moriczi M; Pujol-Muncunill G; Martín-Masot R; Jiménez Treviño S; Segarra Cantón O; Ochoa Sangrador C; Peña Quintana L; González Santana D; Rodríguez Martínez A; Rosell Camps A; Armas H; Barrio J; González de Caldas R; Rodríguez Salas M; Balmaseda Serrano E; Donat Aliaga E; Bodas Pinedo A; Vaquero Sosa E; Vecino López R; Solar Boga A; Moreno Álvarez A; Sánchez Sánchez C; Tolín Hernani M; Gutiérrez Junquera C; Martinón Torres N; Leis Trabazo MR; Eizaguirre FJ; García Peris M; Medina Benítez E; Fernández Caamaño B; Vegas Álvarez AM; Crespo Valderrábano L; Alonso Vicente C; Rubio Santiago J; Galera-Martínez R; García-Romero R; Ros Arnal I; Fernández Cebrián S; Lorenzo Garrido H; Viada Bris JF; Velasco Rodríguez-Belvis M; Bartolomé Porro JM; Blanco Rodríguez M; Barros García P; Botija G; Chicano Marín FJ; La Orden Izquierdo E; Crehuá-Gaudiza E; Navas-López VM; Martín-de-Carpi J
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32272604
[TBL] [Abstract][Full Text] [Related]
20. Exclusive enteral nutrition effect on the clinical course of pediatric Crohn's disease: a single center experience.
Scarpato E; Strisciuglio C; Martinelli M; Russo M; Cenni S; Casertano M; Serra MR; Staiano A; Miele E
Eur J Pediatr; 2020 Dec; 179(12):1925-1934. PubMed ID: 32734315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
